The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A real-world study of the association between nivolumab exposure and efficacy in patients with metastatic melanoma.
 
Clara Boeri
No Relationships to Disclose
 
Quentin Gerbault
No Relationships to Disclose
 
Nausicaa Malissen
No Relationships to Disclose
 
Paul Maroselli
No Relationships to Disclose
 
Caroline Gaudy-Marqueste
Honoraria - BMS france; Pierre Fabre; UCB
Consulting or Advisory Role - Bristol Meyer Squib; Iovance Biotherapeutics; MSD Oncology; Pierre Fabre; Regeneron; Sun Pharma
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cytovation (Inst); Daiichi Sankyo Europe GmbH (Inst); Day One Biopharmaceuticals (Inst); DOT therapeutics (Inst); Dragonfly Therapeutics (Inst); Erasca, Inc (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); IFX (Inst); Immunocore (Inst); Incyte (Inst); IO Biotech (Inst); Janssen (Inst); Kartos Therapeutics (Inst); Kinnate Biopharma (Inst); Merck (Inst); Microbiotica (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Philogen (Inst); Pierre Fabre (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Sairopa (Inst); Sotio (Inst)
Travel, Accommodations, Expenses - BMS France; MSD Oncology; Pierre Fabre
 
Joseph Ciccolini
Honoraria - Accord Healthcare; Daiichi Sankyo Europe GmbH; Edimark; Eisai; GlaxoSmithKline; Merck Serono; Pfizer; Pierre Fabre; Promise Proteomics; Roche (Inst); Roche/Genentech; Samsung bioepis
Research Funding - Merck Serono (Inst); Roche (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche